Lab marker

HbA1c

Glycated haemoglobin · Haemoglobin A1c

A two-to-three-month moving average of blood glucose. The most stable single marker of glycaemic regulation.

Strong relevance6 cited sourcesNo fasting€10–20 private.nutritionmovement

What it measures

Glucose binds non-enzymatically to haemoglobin in red blood cells. Because red cells live ~120 days, HbA1c reflects average glucose exposure across the prior 8–12 weeks. Reported as % (NGSP) or mmol/mol (IFCC).

Reference context

4 guideline sources

Lab 'normal' ranges typically end at 6.0–6.4%. Observational data suggest cardiovascular risk begins rising above ~5.6%, though this is associative and not a treatment target. Recent data on continuous glucose monitoring complement HbA1c by exposing post-meal excursions that the average can hide.

Population context: consult guideline targets below

Mechanism

Why moving this marker matters

Hyperglycaemia drives glycation of structural proteins (advanced glycation end-products), endothelial dysfunction, microvascular damage, and accelerated atherosclerosis. Each 1% increase in HbA1c above 5.5% is associated with stepwise increases in cardiovascular and all-cause mortality in prospective cohorts.

Guideline targets

What major guidelines recommend

ADA 2024 (normal)

Strong

<5.7% (<39 mmol/mol)

ADA 2024 (prediabetes)

Strong

5.7–6.4% (39–46 mmol/mol)

ADA 2024 (diabetes)

Strong

≥6.5% (≥48 mmol/mol)

NICE PH38 (high risk / non-diabetic hyperglycaemia)

Strong

42–47 mmol/mol (6.0–6.4%)

How to measure

The test, where to get it, when to repeat

Method

Standard blood draw. Fasting not required (advantage over fasting glucose).

Where

GP standard preventive panel or private lab.

Typical cost

€10–20 private.

Fasting

Not required

When to test

  • USPSTF 2021

    35–70

    Screen for prediabetes/diabetes in adults 35–70 who are overweight or obese; every 3 years if normal.

  • ADA 2024

    35+

    Universal screening from age 35; every 3 years if normal, annually if prediabetic.

  • NICE PH38

    Risk assessment from age 40, or from 25 in people of South Asian, Chinese, African-Caribbean or Black African family background; a blood test (HbA1c or fasting glucose) if the risk score is high.

Where to test

Independent labs offering this test

Healicus refers you to independent laboratories. You order from the lab; they take the sample, run it, and return your result on their own platform. Healicus never sees your value.

Healicus is not the provider. Your contract for the service is with whoever you choose. Links labelled Sponsored are paid affiliate relationships; unlabelled links are editorial reference only. See our disclosure for the full policy.

Context

Reading the numbers

Lab 'normal' ranges typically end at 6.0–6.4%. Observational data suggest cardiovascular risk begins rising above ~5.6%, though this is associative and not a treatment target. Recent data on continuous glucose monitoring complement HbA1c by exposing post-meal excursions that the average can hide.

Caveats

Conditions affecting red cell turnover (anaemia, haemoglobinopathies, recent transfusion, pregnancy) make HbA1c unreliable; use fasting glucose or OGTT instead.

Practices

What's been shown to influence this marker

In a PREDIMED subgroup without diabetes at baseline, Mediterranean diets (without calorie restriction) led to fewer new cases of type 2 diabetes than a low-fat control diet; the report did not give HbA1c changes.

Mediterranean dietary patternHabit
Moderate evidence

Mediterranean dietary pattern

Olive oil, fish, nuts, legumes, plants. Two randomised trials found fewer major cardiovascular events than a low-fat diet.

Read full evidence

Why

The Mediterranean pattern, heavy on plants, olive oil, fish, nuts, legumes; moderate fish and dairy; light on red meat, has randomised-trial evidence for fewer major cardiovascular events than a low-fat diet in adults at high cardiovascular risk. PREDIMED, the largest trial (republished after protocol deviations), showed ~30% fewer major cardiovascular events vs. low-fat control. Trial evidence for cognition is thin.

Slot in your day

With a meal

How to do it

How

Olive oil as the primary fat. Plants at every meal. Fish 2–3× per week. Nuts daily (small handful). Red meat once a week or less. Alcohol is not needed for the pattern; low-volume drinking has not been shown to be protective.

Sticking with it

Stock the kitchen for one week's pattern. Decisions live in the shopping list, not at mealtime.

Markers this may influence

Evidence

At a glance

Estruch 2018 N Engl J Med RCT (n=7,447, adults at high cardiovascular risk, republished after protocol deviations): a Mediterranean diet with olive oil or nuts had fewer major cardiovascular events than a control diet advising less fat (hazard ratios 0.69 and 0.72). Delgado-Lista 2022 Lancet RCT (n=1,002, coronary heart disease) found a similar direction versus a low-fat diet, mainly in men. Trial evidence for cognition is thin.

GRADE certainty: Moderate — rated by Healicus using the GRADE method (RCT evidence; downgraded for protocol deviations/no blinding in the main trials and for indirectness of dietary-pattern comparisons)

See also

Related markers

Take to your physician

Worth discussing

  • Whether your HbA1c, fasting glucose, and clinical picture warrant further workup (OGTT, insulin, HOMA-IR).
  • If you're in the 5.7–6.4% range, what lifestyle changes have the best evidence in your situation.
  • Whether anaemia or other red-cell conditions might be making your HbA1c unreliable.

Sources

Cited literature

Last reviewed October 2026

Educational reference. Population-level information for the longevity-curious reader. Healicus does not compute scores, interpret your specific values, or produce personalised recommendations from your clinical data. Discuss your own results and any decisions with your physician.

Keep reading